These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 36611025
1. Effects of peripheral blood leukocyte count and tumor necrosis factor-alpha on early death in acute promyelocytic leukemia. Wen J, Xu F, Zhou Q, Shi L, Liu Y, Yue J, Zhang Y, Liang X. BMC Cancer; 2023 Jan 07; 23(1):27. PubMed ID: 36611025 [Abstract] [Full Text] [Related]
2. Does leukocytosis remain a predictive factor for survival outcomes in patients with acute promyelocytic leukemia receiving ATRA plus a chemotherapy-based regimen? A prospective multicenter analysis from TALWG. Kungwankiattichai S, Owattanapanich W, Rattanathammethee T, Rattarittamrong E, Chanswangphuwana C, Polprasert C, Limvorapitak W, Saengboon S, Niparuck P, Puavilai T, Julamanee J, Saelue P, Wanitpongpun C, Prayongratana K, Sriswasdi C, Nakhakes C. Hematology; 2023 Dec 07; 28(1):2191462. PubMed ID: 36951362 [Abstract] [Full Text] [Related]
3. The kinetics of white blood cell and the predictive factors of leukocytosis under oral or intravenous arsenic as the first-line treatment for acute promyelocytic leukemia. Wang F, Jia JS, Wang J, Zhao T, Jiang Q, Jiang H, Zhu HH. Leuk Res; 2017 Oct 07; 61():84-88. PubMed ID: 28934679 [Abstract] [Full Text] [Related]
4. Influence of cytokines on early death and coagulopathy in newly diagnosed patients with acute promyelocytic leukemia. Zhao S, Ge Y, Li Z, Yang T. Front Immunol; 2023 Oct 07; 14():1100151. PubMed ID: 37063881 [Abstract] [Full Text] [Related]
5. Survival and risk factors for mortality in pediatric patients with acute myeloid leukemia in a single reference center in low-middle-income country. Lins MM, Mello MJG, Ribeiro RC, De Camargo B, de Fátima Pessoa Militão de Albuquerque M, Thuler LCS. Ann Hematol; 2019 Jun 07; 98(6):1403-1411. PubMed ID: 30915498 [Abstract] [Full Text] [Related]
6. Gene mutations in acute promyelocytic leukemia early death in patients treated with arsenic trioxide alone. Chen X, Fan S, Zhao Y, Zhou J. Clin Transl Oncol; 2021 Oct 07; 23(10):2171-2180. PubMed ID: 33942222 [Abstract] [Full Text] [Related]
7. Treatment of acute promyelocytic leukemia with PETHEMA LPA 99 protocol: a Tunisian single center experience. Jeddi R, Ghédira H, Menif S, Ben Neji H, Ben Amor R, Kacem K, Aissaoui L, Bouteraâ W, Abdennebi Y, Raihane BL, Gouider E, Raouf H, Hèla BA, Saad A, Zaher B, Meddeb B. Hematology; 2010 Aug 07; 15(4):204-9. PubMed ID: 20670478 [Abstract] [Full Text] [Related]
8. High body mass index is an independent predictor of differentiation syndrome in patients with acute promyelocytic leukemia. Jeddi R, Ghédira H, Mnif S, Gouider E, Fenaux P, Meddeb B. Leuk Res; 2010 Apr 07; 34(4):545-7. PubMed ID: 19800119 [Abstract] [Full Text] [Related]
9. Clinical Characteristics and Treatment Outcomes of Childhood Acute Promyelocytic Leukemia in Korea: A Nationwide Multicenter Retrospective Study by Korean Pediatric Oncology Study Group. Park KM, Yoo KH, Kim SK, Lee JW, Chung NG, Ju HY, Koo HH, Lyu CJ, Han SM, Han JW, Choi JY, Hong KT, Kang HJ, Shin HY, Im HJ, Koh KN, Kim H, Kook H, Baek HJ, Kim BR, Yang EJ, Lim JY, Park ES, Choi EJ, Park SK, Lee JM, Shim YJ, Kim JY, Park JK, Kong SG, Choi YB, Cho B, Lim YT. Cancer Res Treat; 2022 Jan 07; 54(1):269-276. PubMed ID: 33887821 [Abstract] [Full Text] [Related]
10. Characteristics features and factors influencing early death in Acute promyelocytic leukemia; Experience from United Arab Emirates (UAE). Hassan IB, Zaabi MRA, Alam A, Hashim MJ, Tallman MS, Kristensen J. Int J Hematol; 2017 Jul 07; 106(1):90-98. PubMed ID: 28293819 [Abstract] [Full Text] [Related]
11. Influence of initiation time and white blood cell count on the efficacy of cytotoxic agents in acute promyelocytic leukemia during induction treatment. Xu F, Yin CX, Wang CL, Ding BJ, Zhong QX, Jiang XJ, Jiang L, Wang ZX, Meng FY. Biomed Rep; 2018 Sep 07; 9(3):227-232. PubMed ID: 30271598 [Abstract] [Full Text] [Related]
13. Predictors of early death and clinical features in newly diagnosed patients with low-intermediate risk acute promyelocytic leukemia. Wen J, Xu F, Zhou Q, Shi L, Liu Y, Yue J, Zhang Y, Liang X. Front Oncol; 2022 Sep 07; 12():895777. PubMed ID: 36185183 [Abstract] [Full Text] [Related]
15. Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group. De Botton S, Dombret H, Sanz M, Miguel JS, Caillot D, Zittoun R, Gardembas M, Stamatoulas A, Condé E, Guerci A, Gardin C, Geiser K, Makhoul DC, Reman O, de la Serna J, Lefrere F, Chomienne C, Chastang C, Degos L, Fenaux P. Blood; 1998 Oct 15; 92(8):2712-8. PubMed ID: 9763554 [Abstract] [Full Text] [Related]
16. Interleukin-8 is not a predictive biomarker for the development of the acute promyelocytic leukemia differentiation syndrome. Yamamoto de Almeida L, Pereira-Martins DA, Lima ASG, Baggio MS, de Araujo Koury LC, Lange AP, Bassi SC, Scheucher PS, Rego EM. BMC Cancer; 2020 Aug 28; 20(1):821. PubMed ID: 32859169 [Abstract] [Full Text] [Related]
17. Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapy. Abla O, Ribeiro RC, Testi AM, Montesinos P, Creutzig U, Sung L, Di Giuseppe G, Stephens D, Feusner JH, Powell BL, Hasle H, Kaspers GJL, Dalla-Pozza L, Lassaletta A, Tallman MS, Locatelli F, Reinhardt D, Lo-Coco F, Hitzler J, Sanz MA. Ann Hematol; 2017 Sep 28; 96(9):1449-1456. PubMed ID: 28597167 [Abstract] [Full Text] [Related]
19. Characteristics and predictors of early hospital deaths in newly diagnosed APL: a 13-year population-wide study. Gill H, Yung Y, Chu HT, Au WY, Yip PK, Lee E, Yim R, Lee P, Cheuk D, Ha SY, Leung RYY, Ma ESK, Kumana CR, Kwong YL. Blood Adv; 2021 Jul 27; 5(14):2829-2838. PubMed ID: 34269798 [Abstract] [Full Text] [Related]